These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 9805460)

  • 1. [Metastasized carcinoid tumor treated with interferon and octreotide].
    Szilvás A; Székely G; Szilvási I; Jakab F
    Orv Hetil; 1998 Oct; 139(41):2455-8. PubMed ID: 9805460
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The importance of follow-up examinations in patients with carcinoid tumor.
    Szilvás A; Székely G; Szilvási I; Sági S; Jakab F
    Hepatogastroenterology; 2003; 50(53):1452-3. PubMed ID: 14571761
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of octreotide in the regression of a metastatic carcinoid tumour despite negative imaging with In-111-pentetreotide (Octreoscan).
    Hillman N; Herranz L; Alvarez C; Martínez Olmos MA; Márco A; Gómez-Pan A
    Exp Clin Endocrinol Diabetes; 1998; 106(3):226-30. PubMed ID: 9710364
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [A case of rectal carcinoid with multiple liver, lymph nodes and bone metastases that responded to an octreotide therapy].
    Yamashita K; Takase S; Nakamura T; Matsuda Y; Imanishi T; Sumi Y; Suzuki S; Kamigaki T; Ku Y; Kuroda D
    Gan To Kagaku Ryoho; 2010 Nov; 37(12):2349-51. PubMed ID: 21224569
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Two cases of thymic carcinoid treated with octreotide long-acting repeatable].
    Okabe N; Inoue T; Watanabe Y; Muto S; Hasegawa T; Ohsugi J; Higuchi M; Shio Y; Suzuki H
    Gan To Kagaku Ryoho; 2014 Jul; 41(7):879-83. PubMed ID: 25131876
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Treatment of carcinoid tumor with a long-acting somatostatin analog].
    Werling K; Lengyel G; Fehér E; Jakab Z; Besznyák I; Feher J
    Orv Hetil; 1993 Feb; 134(6):301-5. PubMed ID: 8430017
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regression of metastatic carcinoid tumors with octreotide therapy: two case reports and a review of the literature.
    Leong WL; Pasieka JL
    J Surg Oncol; 2002 Mar; 79(3):180-7. PubMed ID: 11870669
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-standing malignant pancreatic carcinoid treated with octreotide.
    Varas-Lorenzo MJ
    Rev Esp Enferm Dig; 2010 Nov; 102(11):662-6. PubMed ID: 21142389
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Octreotide scanning for carcinoid tumours.
    Critchley M
    Postgrad Med J; 1997 Jul; 73(861):399-402. PubMed ID: 9338023
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thymic carcinoid responds to neoadjuvant therapy with sunitinib and octreotide: a case report.
    Dham A; Truskinovsky AM; Dudek AZ
    J Thorac Oncol; 2008 Jan; 3(1):94-7. PubMed ID: 18166847
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epidemiology and survival in patients with carcinoid disease in The Netherlands. An epidemiological study with 2391 patients.
    Quaedvlieg PF; Visser O; Lamers CB; Janssen-Heijen ML; Taal BG
    Ann Oncol; 2001 Sep; 12(9):1295-300. PubMed ID: 11697843
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Randomized clinical trial of the effect of interferon alpha on survival in patients with disseminated midgut carcinoid tumours.
    Kölby L; Persson G; Franzén S; Ahrén B
    Br J Surg; 2003 Jun; 90(6):687-93. PubMed ID: 12808615
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical efficacy of octreotide in the treatment of metastatic neuroendocrine tumors. A study by the Italian Trials in Medical Oncology Group.
    di Bartolomeo M; Bajetta E; Buzzoni R; Mariani L; Carnaghi C; Somma L; Zilembo N; di Leo A
    Cancer; 1996 Jan; 77(2):402-8. PubMed ID: 8625251
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The treatment of carcinoid of the small intestine with octreotide and alpha-interferon. A call for participation in a randomized study].
    Ahrén B
    Dtsch Med Wochenschr; 1996 May; 121(22):744-5. PubMed ID: 8646989
    [No Abstract]   [Full Text] [Related]  

  • 15. [Management of digestive system carcinoid tumors and carcinoid syndrome].
    Mondragón Sánchez RJ; Castillero Pinilla C; Saldívar Moreno C; Oñate Ocaña LF; Ruiz Molina JM; Aiello Crocifoglio V
    Rev Gastroenterol Mex; 1998; 63(4):204-10. PubMed ID: 10319670
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficient symptomatic control of carcinoid tumors with somatostatin in patients with disease progression under alpha-interferon therapy.
    Boehme MW; Schmidt-Gayk H; Bihl H; Eisenhut M; Herfarth CH; Kommere B; Raeth U
    Hepatogastroenterology; 1995; 42(6):1053-61. PubMed ID: 8847018
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Successful treatment of carcinoid syndrome in two cases of bronchial carcinoid].
    Katakami N; Matsumoto H; Ishihara K; Umeda B
    Nihon Kyobu Shikkan Gakkai Zasshi; 1995 Nov; 33(11):1313-8. PubMed ID: 8583728
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Treatment with octreotide (SMS 201-995) in a case of intestinal carcinoid tumor].
    Goñi F; Oleaga A; Goñi MJ; Monreal M; Yoldi A; González A; Llorente I; Moncada E
    Rev Clin Esp; 1991 Nov; 189(7):331-4. PubMed ID: 1722585
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comments on "Clinical value of monitoring plasma octreotide levels during chronic octreotide long-acting repeatable therapy in carcinoid patients".
    Schran HF; Hager DF
    Pancreas; 2008 Oct; 37(3):334-5; author reply 336-7. PubMed ID: 18815560
    [No Abstract]   [Full Text] [Related]  

  • 20. Carcinoid tumours.
    Janmohamed S; Bloom SR
    Postgrad Med J; 1997 Apr; 73(858):207-14. PubMed ID: 9156122
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.